Core Viewpoint - Shenzhen Xipuni Precision Technology Co., Ltd. has issued a positive profit forecast, indicating a significant increase in net profit for the fiscal year ending December 31, 2025, compared to the previous year [1] Group 1: Stock Performance - As of December 24, 2025, Xipuni's stock closed at 167.4 yuan, up 1.52% from the previous trading day [1] - The stock opened at 165.4 yuan, reached a high of 167.7 yuan, and a low of 163.2 yuan, with a trading volume of 5.8312 million yuan [1] - Over the past 52 weeks, the stock has seen a high of 201.8 yuan and a low of 80.0 yuan [1] Group 2: Financial Performance - For the eleven months ending November 30, 2025, the company recorded a net profit exceeding 90 million yuan [1] - The expected net profit for the fiscal year ending December 31, 2025, is projected to be higher than the previous year's net profit by approximately 49 million yuan [1] - The profit growth is attributed to increased sales revenue from jewelry and improved gross profit margins from watch sales [1] Group 3: Future Reporting - The financial results will be disclosed in the annual performance announcement to be released by the end of March 2026 [1] - The data presented is based on unaudited consolidated management accounts and has not been reviewed by auditors or the audit committee [1]

Group 1 - The company, Xipuni (02583.HK), reported a net profit exceeding RMB 90 million for the 11 months ending November 30, 2025, compared to a net profit of approximately RMB 49 million for the year ending December 31, 2024 [1] - The expected increase in net profit for the year ending 2025 is primarily driven by an increase in sales revenue from jewelry and an improvement in the gross margin from watch sales [1]

Major Events - Kuaishou-W (01024) strongly condemns illegal activities related to black and gray industries, has reported to law enforcement and relevant authorities [1] - Sihon Pharmaceutical (02096) receives clinical trial approval for SIM0610 (EGFR/cMET bispecific antibody-drug conjugate) from the National Medical Products Administration [1] - Sinopec Engineering (02386) plans to acquire 100% equity of East China Pipeline Design Institute [1] - Yanda Pharmaceutical (00512) introduces the world's first epinephrine nasal spray for treating severe allergic reactions [1] - Valiant Pharmaceuticals-B (09887) reports the first subject has been dosed in Phase I trial of LBL-047 [1] - Xinyi Energy (03868) intends to acquire 100% equity of Jinzhai Xinyi Wind Power for 62 million yuan [1] - Zhongneng Holdings (00228) plans to receive a premium of approximately 9.03% for a full acquisition offer, with resumption of trading on December 24 [1] Operating Performance - Xipuni (02583) issues a profit warning, expecting annual net profit to increase year-on-year [1] - AEON CREDIT (00900) reports a profit of 353 million HKD for the first three quarters, an increase of 28.11% year-on-year [1] - New Fire Technology Holdings (01611) anticipates an annual net loss not exceeding 10 million HKD [1]

Core Viewpoint - The company, Xipuni (02583.HK), anticipates a significant increase in net profit for the fiscal year ending December 31, 2025, projecting over RMB 90 million compared to approximately RMB 49 million for the fiscal year ending December 31, 2024 [1] Financial Performance - The preliminary review of the unaudited consolidated management accounts indicates a net profit exceeding RMB 90 million for the eleven months ending November 30, 2025 [1] - The expected growth in net profit is primarily attributed to an increase in sales revenue from jewelry and an improvement in the gross margin from watch sales [1]

Core Viewpoint - The company, Xipuni (02583), anticipates a significant increase in net profit for the fiscal year ending December 31, 2025, projecting over RMB 90 million compared to approximately RMB 49 million for the fiscal year ending December 31, 2024 [1] Group 1: Financial Performance - The company recorded a net profit exceeding RMB 90 million for the 11 months ending November 30, 2025, based on preliminary unaudited consolidated management accounts [1] - The expected growth in net profit is primarily attributed to an increase in sales revenue from jewelry and an improvement in the gross margin from watch sales [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不就因本公告全部或任 何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 SHENZHEN HIPINE PRECISION TECHNOLOGY CO., LTD. 深 圳 西 普 尼 精 密 科 技 股 份 有 限 公 司 本公告所載資料僅根據董事會對本集團截至二零二五年十一月三十日止十一個月以香港普遍採 納之會計準則編製之未經審核綜合管理帳目之初步評估及本集團之現有資料而作出，該等資料 尚未經公司審計師審閱、確認或審計或公司審計委員會審閱。本集團截至二零二五年十二月三 十一日止年度之財務業績將載列於本公司之年度業績公告，該公告將於二零二六年三月底前刊 發。 本公司股東及有意投資者於買賣本公司股份時，務請審慎行事。 承 董 事 會 命 深 圳 西 普 尼 精 密 科 技 股 份 有 限 公 司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：2583） 正面盈利預告 本公告由深圳西普尼精密科技股份有限公司（「本公司」，連同其附屬公司，統稱「本集團」） 根據香港聯合 ...

Group 1: Company Overview - Xipuni (02583) has quickly become a market focus since its IPO on September 30, 2023, with a first-day surge of 258% and a total increase of nearly 480%, surpassing a market capitalization of HKD 10 billion [1] - The company primarily sells gold watches under its flagship brand "HIPINE," and is the largest gold watch brand in China with a market share of 27.08% as of 2024 [7] - Xipuni's revenue from 2022 to 2024 showed a gradual increase from HKD 324 million to HKD 457 million, but the growth rate has significantly slowed down in 2024 [7] Group 2: Market Performance and Trading Dynamics - The extreme concentration of shares, with over 90% locked in by cornerstone investors and large international placements, created a favorable environment for price manipulation, leading to a significant price increase despite low trading volume [2] - The trading volume dropped from 2.82 million shares on the first day to 620,000 shares by the third day, indicating a classic "volume-price divergence" [2] - The current turnover rate is around 0.1%, confirming that the initial price surge was not driven by market consensus but rather by a limited supply of shares [2] Group 3: Market Expectations and Stock Connect - The market is particularly focused on Xipuni's potential inclusion in the Stock Connect program, which could significantly increase trading volume and attract mainland capital [3] - As of December 15, 2023, Xipuni's average market capitalization was HKD 9.848 billion, just above the threshold for inclusion in the Stock Connect [3] - The trading structure indicates a "stabilization" operation, with smaller brokers executing short-term trades while larger investment banks maintain a more cautious approach [4] Group 4: Challenges and Risks - Xipuni faces significant competition in the gold watch market, with the top five brands holding a combined market share of 37.48%, and must compete with both international luxury brands and domestic smart watch giants [8] - The company has a high customer concentration, with over 87% of sales revenue coming from the top five clients, which increases operational volatility and dependency on a few key customers [8] - Despite a recovery in revenue growth in early 2025, the current market capitalization of over HKD 10 billion lacks solid financial backing, raising concerns about sustainability [7][8]

Group 1 - The core viewpoint of the articles highlights the remarkable market performance of Xipuni (02583) since its IPO on September 30, 2023, with a cumulative increase of nearly 480% and a market capitalization exceeding HKD 10 billion, making it a standout in the 2025 Hong Kong IPO market [1] - The surge in Xipuni's stock price is primarily attributed to expectations of its inclusion in the Hong Kong Stock Connect, rather than fundamental changes in the company's performance [1][3] - The company's share structure, with only 10% of its total 10.6 million shares available for public subscription, has led to a highly concentrated float, creating an environment conducive to price manipulation by major investors [2] Group 2 - Xipuni's market performance is closely linked to its potential entry into the Hong Kong Stock Connect, which could significantly increase trading volume and attract mainland capital [3] - The company has achieved a market share of 27.08% in the gold watch segment in China, positioning itself as the largest brand in this category by GMV in 2024 [6][8] - Despite its leading position, Xipuni faces challenges such as high customer concentration, with over 87% of sales revenue coming from its top five clients, which increases operational volatility and dependence on a few key customers [9]

致：香港交易及結算所有限公司 公司名稱: 深圳西普尼精密科技股份有限公司（於中華人民共和國註冊成立的股份有限公司） 呈交日期: 2025年12月3日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | H | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02583 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 58,825,000 | RMB | | | 1 RMB | | 58,825,000 | | 增加 / 減少 (-) | | | | | | | RMB | | | | 本月底結存 | | | 58,825,000 | RMB | | | 1 RMB | | 58,825,000 | 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年11月30日 狀態: ...

Group 1 - The company has appointed Mr. She Dingshun as an independent non-executive director of the fourth board, with Mr. Li Yongzhong, Mr. Hu Shaohua, and Mr. Li Yangjin re-elected as executive directors [1] - The term for the newly appointed directors will last for three years, effective from November 28, 2025 [1] - Mr. Li Yongzhong has been elected as the chairman of the fourth board, while Mr. Hu Shaohua has been appointed as the general manager [1] Group 2 - The fourth supervisory board has been established, with Ms. Yao Xiangping elected as the chairperson of the supervisory board [2] - The term for the supervisory board members will also last for three years, effective from the date of approval by the supervisory board [2] - Ms. Qin Yan has been re-elected as the employee representative supervisor, serving alongside the non-employee representative supervisors [1][2]